StockData
Natures Sunshine Products Inc logo

Natures Sunshine Products Inc (NATR) stock

NATRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3058% below fair value
$10.32−0.01 (-0.10%)

Close on Nov 18, 2026Market cap $181.59MP/E 10.2Yield –

Natures Sunshine Products operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Natures Sunshine Products's operating income for the twelve months ending Jun 30, 2026 was $29.32M, up 44.6% year over year. For fiscal 2025 it was $24.74M, up 23.1% from the year before. Over ten years it grew 6.0% a year on average. The highest annual figure on record is $34.67M in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$24.74M+23.1%
FY2024Dec 31, 2024$20.10M+7.2%
FY2023Dec 31, 2023$18.75M+15.3%
FY2022Dec 31, 2022$16.26M-53.1%
FY2021Dec 31, 2021$34.67M+61.4%
FY2020Dec 31, 2020$21.48M+33.2%
FY2019Dec 31, 2019$16.13M+201.3%
FY2018Dec 31, 2018$5.35M+285.8%
FY2017Dec 31, 2017$1.39M-86.2%
FY2016Dec 31, 2016$10.04M-27.6%
FY2015Dec 31, 2015$13.87M-27.2%
FY2014Dec 31, 2014$19.05M-19.2%
FY2013Dec 31, 2013$23.58M-30.4%
FY2012Dec 31, 2012$33.87M+67.9%
FY2011Dec 31, 2011$20.17M+79.0%
FY2010Dec 31, 2010$11.26M-9.4%
FY2009Dec 31, 2009$12.43M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$5.48M+28.2%
Q1 FY2026Mar 31, 2026$9.55M+54.7%
Q4 FY2025Dec 31, 2025$5.32M+17.0%
Q3 FY2025Sep 30, 2025$8.98M+69.9%
Q2 FY2025Jun 30, 2025$4.27M-24.2%
Q1 FY2025Mar 31, 2025$6.17M+33.5%
Q4 FY2024Dec 31, 2024$4.55M-20.3%
Q3 FY2024Sep 30, 2024$5.28M-9.4%
Q2 FY2024Jun 30, 2024$5.64M-19.9%
Q1 FY2024Mar 31, 2024$4.62M+2588.4%
Q4 FY2023Dec 31, 2023$5.71M+36.5%
Q3 FY2023Sep 30, 2023$5.83M+16.4%
Q2 FY2023Jun 30, 2023$7.04M+22.3%
Q1 FY2023Mar 31, 2023$172.00K-86.9%
Q4 FY2022Dec 31, 2022$4.18M-44.6%
Q3 FY2022Sep 30, 2022$5.01M-49.9%
Q2 FY2022Jun 30, 2022$5.76M-39.3%
Q1 FY2022Mar 31, 2022$1.31M-82.9%
Q4 FY2021Dec 31, 2021$7.54M+235.4%
Q3 FY2021Sep 30, 2021$10.01M+82.9%
Q2 FY2021Jun 30, 2021$9.49M+43.7%
Q1 FY2021Mar 31, 2021$7.64M+6.6%
Q4 FY2020Dec 31, 2020$2.25M-42.5%
Q3 FY2020Sep 30, 2020$5.47M+16.4%
Q2 FY2020Jun 30, 2020$6.60M+45.4%
Q1 FY2020Mar 31, 2020$7.16M+140.5%
Q4 FY2019Dec 31, 2019$3.91M–
Q3 FY2019Sep 30, 2019$4.70M+33.8%
Q2 FY2019Jun 30, 2019$4.54M+107.6%
Q1 FY2019Mar 31, 2019$2.98M+238.0%
Q4 FY2018Dec 31, 2018-$1.23M–
Q3 FY2018Sep 30, 2018$3.51M+63.1%
Q2 FY2018Jun 30, 2018$2.19M+9404.3%
Q1 FY2018Mar 31, 2018$881.00K-57.0%
Q4 FY2017Dec 31, 2017-$2.84M–
Q3 FY2017Sep 30, 2017$2.15M-57.4%
Q2 FY2017Jun 30, 2017$23.00K–
Q1 FY2017Mar 31, 2017$2.05M–
Q4 FY2016Dec 31, 2016-$1.39M–
Q3 FY2016Sep 30, 2016$5.06M–

More Natures Sunshine Products figures

See a number that looks wrong?